Browse through our press and news section by category:

03.06.2016, SCHOTT AG, Mainz, Germany

SCHOTT underscores commitment to Russian pharma market

Five year anniversary of packaging production in Zavolzhe
Photo: SCHOTT AG
Photo: SCHOTT AG
Against the backdrop of the 5th anniversary of its manufacturing site in Zavolzhe, SCHOTT has renewed its commitment to the Russian pharma market. For the international technology group, Eastern Europe represents one of the most exciting regions within the global pharma market, showing significant growth opportunities. “Our intention is to keep working closely with the Russian pharma industry and to support their growth plans by offering just the right packaging solutions,” said Andreas Reisse, Executive Vice President for SCHOTT Pharmaceutical Systems. Every year, the site in Zavolzhe manufactures up to 500 million vials and ampoules. These containers are made of specialty glass and serve the pharma industry to safely package, transport and store medications.

Supporting the “Pharma 2020 Vision”


Innovation and local production are two key features of “Pharma 2020”, an initiative of the Russian government. Launched in 2009, this programme is dedicated to developing the domestic pharmaceutical and medical industry – and it also increases the need for high-quality packaging solutions. “We are seeing continued growth in demand for locally manufactured pharma packaging that also meets all of the international standards,’ says Rüdiger Wagner, Regional Sales Manager. “This is where we can really help the industry making a big step forward.” In fact, SCHOTT was the first international player to open a packaging production in Russia and invested roughly 12 million euros in this field.

The site in Zavolzhe carries out its work in line with the global standards that apply for pharmaceutical manufacturing – the so called GMP principles (Good Manufacturing Practice). These include modern systems and machines, well-trained employees and meeting the respective guidelines for quality assurance.

The second area where SCHOTT works closely with the industry is the development of future-oriented packaging solutions. For example, these include a ready-to-use concept for aseptic filling of medications called adaptiQ®, or pharma vials that bring the phenomenon of glass delamination under control (SCHOTT Vials DC). Industry experts will be discussing these and other innovations and trends during a symposium that accompanies the 5 year anniversary celebration of the plant this week.

SCHOTT is a leading international technology group in the areas of specialty glass and glass-ceramics. The company has more than 130 years of outstanding development, materials and technology expertise and offers a broad portfolio of high-quality products and intelligent solutions. SCHOTT is an innovative enabler for many industries, including the home appliance, pharmaceutical, electronics, optics, automotive and aviation industries. SCHOTT strives to play an important part of everyone’s life and is committed to innovation and sustainable success. The group maintains a global presence with production sites and sales offices in 35 countries. With its workforce of approximately 15,000 employees, sales of 1.93 billion euros were generated in fiscal year 2014/2015. The parent company, SCHOTT AG, has its headquarters in Mainz (Germany) and is solely owned by the Carl Zeiss Foundation. As a foundation company, SCHOTT assumes special responsibility for its employees, society and the environment. www.schott.com
Press contact
SCHOTT AG
Christina Rettig
Public Relations Manager
Hattenbergstraße 10
55122 Mainz
Phone: +49 6131/66-4094
Further information
SCHOTT AG
Salvatore Ruggiero
Vice President Marketing and Communication
Hattenbergstraße 10
55122 Mainz
Phone: +49 6131/66-4140
SCHOTT uses Cookies on this Website to enhance the user experience and provide the best possible Service. By continuing to browse the Website, you consent to our use of Cookies.